Enlicitide Chloride

7 trials 1 recruiting

Filter these 7 trials by condition, phase, country and more.

Open in Search →

7 Registered trials

1 Recruiting

6 Completed trials

1 Sponsors

12 Countries

Phase III

Phase II/III

Phase III: 6 Phase II/III: 1

Sponsors using this IMP

Merck Sharp & Dohme LLC 7

All trials

7 total

A clinical study of enlicitide in children with high cholesterol (MK-0616-029) Recruiting

2024-519068-42-00 Phase II/III 10 countries Merck Sharp & Dohme LLC
A clinical study of enlicitide in people with high cholesterol (MK-0616-037) Ended

2025-521495-54-00 Phase III 2 countries Merck Sharp & Dohme LLC
Extension trial for adults with high cholesterol who completed a MK-0616 clinical trial Ended

2023-504922-20-00 Phase III 9 countries Merck Sharp & Dohme LLC
A Phase 3 Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of MK-0616 in Reducing Major Adverse Cardiovascu… Ended

2022-502781-24-01 Phase III 9 countries Merck Sharp & Dohme LLC
MK-0616 versus Comparators Study in Adults with Hypercholesterolemia Ended

2023-504920-25-00 Phase III 2 countries Merck Sharp & Dohme LLC
MK-0616-013 Ended

2022-502777-42-01 Phase III 3 countries Merck Sharp & Dohme LLC
A clinical study of MK-0616 for people with high amounts of low-density lipoprotein cholesterol Ended

2022-502782-14-00 Phase III 6 countries Merck Sharp & Dohme LLC

Showing 1–7 of 7 trials

← All drugs A–Z